Years Later, MS Drug Ownership Consolidation — M&A Next?
Biogen Idec Inc. (NASDAQ: BIIB) may be a half decade or so late on this move, but as the saying goes "better late than never." The biotech and drug company is the ...Read Full Story »
Posts related to ‘MS drugs’
Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9895)
- Accounting (508)
- Active Trader (4389)
- Aerospace & Defense (229)
- Alternative Energy (1057)
- Analyst Calls (5063)
- Autos (1471)
- Banking & Finance (3788)
- Bankruptcy (281)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1358)
- Consumer Product (794)
- Corporate Governance (1981)
- Dividends & Buybacks (921)
- Earnings (4141)
- Economy (3690)
- Editor's Picks (516)
- ETFs & Mutual Funds (822)
- General (3836)
- Healthcare (1432)
- Housing (1033)
- Industrials (627)
- Infrastructure (596)
- International Markets (4168)
- Internet (2192)
- IPOs & Secondaries (1649)
- Jobs (158)
- Labor (654)
- Media (4201)
- Mergers & Acquisitions (2223)
- Oil & Gas (2567)
- Personal Finance (304)
- Politics (821)
- Polls (33)
- Regulation (1159)
- Retail (2580)
- Rumors (1093)
- Services (294)
- Special Report (373)
- Technology (3819)
- Telecom & Wireless (1689)
- Transportation (581)
- Value Investing (761)
